Table 2 Number of primary and secondary outcome events and the follow-up period
A. Males | ||||
| Â | All | Non-AB | AB for HT | AB for VD |
Primary outcome | 298 (0.4%) | 232 (0.4%) | 14 (0.3%) | 52 (0.5%) |
Femoral fracture | 186 (0.2%) | 143 (0.2%) | 11 (0.2%) | 32 (0.3%) |
Vertebral fracture | 112 (0.1%) | 89 (0.1%) | 3 (0.1%) | 20 (0.2%) |
Number of Deaths | 3377 (4.2%) | 2663 (4.1%) | 121 (2.6%) | 593 (5.4%) |
Follow-up period (days) | 154 [49, 441] | 161 [49, 464] | 154 [53, 392] | 114 [39, 347] |
B. Females | ||||
| Â | All | Non-AB | AB for HT | AB for VD |
Primary outcome | 382 (1.1%) | 347 (1.1%) | 17 (0.7%) | 18 (1.9%) |
Femoral fracture | 252 (0.7%) | 229 (0.7%) | 13 (0.5%) | 10 (1.0%) |
Vertebral fracture | 130 (0.4%) | 118 (0.4%) | 4 (0.2%) | 8 (0.8%) |
Death | 1385 (3.9%) | 1249 (3.9%) | 96 (4.0%) | 40 (4.1%) |
Follow-up period (days) | 147 [48, 429] | 151 [49, 441] | 140 [49, 364] | 98 [37, 329] |